110 results on '"Panteghini, Mauro"'
Search Results
2. Recommendations for Setting a Criterion and Assessing Commutability of Sample Materials Used in External Quality Assessment/Proficiency Testing Schemes.
3. Guidance on Which Calibrators in a Metrologically Traceable Calibration Hierarchy Must Be Commutable with Clinical Samples
4. Recommendations for Setting a Criterion for Assessing Commutability of Secondary Calibrator Certified Reference Materials.
5. Differences between Educational and Regulatory External Quality Assurance/Proficiency Testing Schemes
6. Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders
7. Interpreting EQA—Understanding Why Commutability of Materials Matters
8. Clinicians at Crossroads for a Dangerous Interference in Neonatal Bilirubin Determination at the Point-of-Care.
9. A Comment about Analytical Performance Specifications for the Combined Measurement Uncertainty Budget in the Implementation of Metrological Traceability of Parathyroid Hormone.
10. Interpreting EQA--Understanding Why Commutability of Materials Matters.
11. Verification of Harmonization of Serum Total and Free Prostate-Specific Antigen (PSA) Measurements and Implications for Medical Decisions
12. Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice
13. Measurement of Serum Neuron-Specific Enolase in Neuroblastoma: Is There a Clinical Role?
14. IFCC Working Group Recommendations for Correction of Bias Caused by Noncommutability of a Certified Reference Material Used in the Calibration Hierarchy of an End-User Measurement Procedure
15. Optimizing Available Tools for Achieving Result Standardization: Value Added by Joint Committee on Traceability in Laboratory Medicine (JCTLM).
16. Trueness Evaluation and Verification of Interassay Agreement of 11 Serum IgA Measuring Systems: Implications for Medical Decisions
17. How Clinical Laboratories May Improve Their Performance: The “High-Sensitivity” Troponin Paradigm
18. IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design
19. IFCC Working Group Recommendations for Assessing Commutability Part 3: Using the Calibration Effectiveness of a Reference Material
20. IFCC Working Group Recommendations for Assessing Commutability Part 2: Using the Difference in Bias between a Reference Material and Clinical Samples
21. Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice
22. American Liver Guidelines and Cutoffs for “Normal” ALT: A Potential for Overdiagnosis
23. IFCC Working Group Recommendations for Assessing Commutability Part 1:General Experimental Design.
24. The Changing Face of Laboratory Medicine: A More Service and Less Academically Oriented Profession?
25. Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation.
26. Gaps in the Traceability Chain of Human Growth Hormone Measurements
27. Fatal Electrolyte Abnormalities Following Enema Administration
28. The Analytical Goals for Hemoglobin A1c Measurement in IFCC Units and National Glycohemoglobin Standardization Program Units Are Different
29. Impact of Implementation of the High-Sensitivity Cardiac Troponin T Assay in a University Hospital Setting
30. Pretreatment of Serum with Penicillamine: Effects on Capillary Electrophoresis Patterns and on Immunonephelometric Measurement of Immunoglobulins
31. Standardization of Cardiac Troponin I Measurements: The Way Forward?
32. Selection of Antibodies and Epitopes for Cardiac Troponin Immunoassays: Should We Revise Our Evidence-Based Beliefs?
33. AACC Creatine Kinase MB (CK-MB) Standardization Material Used as Manufacturer’s Working Calibrator Is Unable to Harmonize CK-MB Results between Two Commercial Immunoassays
34. Multicenter Evaluation of the TOSOH AIA-Pack Second-Generation Cardiac Troponin I Assay
35. Innotrac Aio! Second-Generation Cardiac Troponin I Assay: Imprecision Profile and Other Key Characteristics for Clinical Use
36. The Interfering Component in Cardiac Troponin I Immunoassays: Need for Further Experimental Evidence
37. Single-Point Cardiac Troponin T at Coronary Care Unit Discharge after Myocardial Infarction Correlates with Infarct Size and Ejection Fraction
38. Performance of Today’s Cardiac Troponin Assays and Tomorrow’s
39. Laboratory Community Should Be More Proactive in Highlighting the Negative Impact of Analytical Non-Selectivity of Some Creatinine Assays.
40. 5′-Nucleotidase in the Detection of Increased Activity of the Liver Form of Alkaline Phosphatase in Serum
41. Standardization of Cardiac Troponin I Assays: Round Robin of Ten Candidate Reference Materials
42. Biological Variation in Serum Activities of Three Hepatic Enzymes
43. Biological Variation in Serum Type I Collagen Carboxy-Terminal Telopeptide Concentrations
44. Serum and Plasma Samples for ACS:Systems Cardiac Markers
45. Evaluation of Two Automated Immunoassays for Measurement of Free Deoxypyridinoline in Urine Using Analytical Goals Derived from Biological Variation
46. Clinical Pathology of Pancreatic Disorders.
47. Biological Variation of Myoglobin in Serum
48. Cardiac Troponin T in Serum as Marker for Myocardial Injury in Newborns
49. Rapid, Highly Sensitive Immunoassay for Determination of Cardiac Troponin I in Patients with Myocardial Cell Damage
50. Automated Immunoassay of Cardiac Troponin I in Serum Evaluated
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.